ES2150487T3 - Tapon escleral biodegradable. - Google Patents

Tapon escleral biodegradable.

Info

Publication number
ES2150487T3
ES2150487T3 ES94907661T ES94907661T ES2150487T3 ES 2150487 T3 ES2150487 T3 ES 2150487T3 ES 94907661 T ES94907661 T ES 94907661T ES 94907661 T ES94907661 T ES 94907661T ES 2150487 T3 ES2150487 T3 ES 2150487T3
Authority
ES
Spain
Prior art keywords
drug
surgical operation
shutter
vitreous
vitreous body
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94907661T
Other languages
English (en)
Inventor
Yuichiro Ogura
Yoshito Ikada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2150487T3 publication Critical patent/ES2150487T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00004—(bio)absorbable, (bio)resorbable or resorptive

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

LA INVENCION SE REFIERE A UN OBTURADOR ESCLEROTICO QUE CONSTA DE UN LACTOCOPOLIMERO, A UN OBTURADOR ESCLEROTICO QUE CONTIENE UNA DROGA Y QUE ESTA DISEÑADO DE MANERA QUE LIBERE LA DROGA GRADUALMENTE A INTERIOR DEL CUERPO VITREO, Y A UN OBTURADOR ESCLEROTICO UTILIZADO PARA CURAR O EVITAR UNA ENFERMEDAD RETINAL UTILIZANDO LA ACCION DE LA LIBERACION SOSTENIDA DE LA DROGA Y QUE PROMUEVA LA CURACION DEL CUERPO VITREO DESPUES DE UNA OPERACION QUIRURGICA SOBRE EL MISMO. EL OBTURADOR ESCLEROTICO DE ACUERDO CON LA INVENCION CIERRA DE FORMA EFECTIVA UNA ABERTURA HECHA DURANTE UNA OPERACION QUIRURGICA SOBRE EL CUERPO VITREO, Y QUE NO NECESITE SER ELIMINADO DESPUES DE LA OPERACION QUIRURGICA. CUANDO SE UTILIZA ESTE OBTURADOR ESCLEROTICO, UNA DROGA PUEDE LIBERARSE GRADUALMENTE DURANTE UN LARGO PERIODO DE TIEMPO EN EL INTERIOR DEL TEJIDO INTRAOCULAR DENTRO DEL CUAL LA PERMEABILIDAD DE LA DROGA SERIA DE OTRA MANERA MUY DIFICULTOSA, DE MANERA QUE LA ADMINISTRACION DE UNA DROGA PUEDA LLEVARSE A CABO DE FORMASEGURA Y EFECTIVA. MAS AUN, PUEDE ENCONTRARSE UN METODO DE ADMINISTRACION SIMPLE Y CLINICAMENTE APLICABLE UTILIZANDO UN CORTE ESCLEROTICO HECHO DURANTE UNA OPERACION QUIRURGICA SOBRE UN CUERPO VITREO.
ES94907661T 1993-02-26 1994-02-23 Tapon escleral biodegradable. Expired - Lifetime ES2150487T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6281493 1993-02-26
JP6945793 1993-03-04

Publications (1)

Publication Number Publication Date
ES2150487T3 true ES2150487T3 (es) 2000-12-01

Family

ID=26403867

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94907661T Expired - Lifetime ES2150487T3 (es) 1993-02-26 1994-02-23 Tapon escleral biodegradable.

Country Status (12)

Country Link
EP (1) EP0654256B1 (es)
KR (1) KR100313268B1 (es)
AT (1) ATE195065T1 (es)
CA (1) CA2118515A1 (es)
DE (1) DE69425411T2 (es)
DK (1) DK0654256T3 (es)
ES (1) ES2150487T3 (es)
FI (1) FI945014A0 (es)
GR (1) GR3034526T3 (es)
NO (1) NO303665B1 (es)
PT (1) PT654256E (es)
WO (1) WO1994018921A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010014384A (ko) 1997-07-02 2001-02-26 모리타 다카카즈 폴리락트산 공막 플러그
US6991650B2 (en) 1997-10-08 2006-01-31 Refocus Ocular, Inc. Scleral expansion device having duck bill
US7008396B1 (en) 1999-09-03 2006-03-07 Restorvision, Inc. Ophthalmic device and method of manufacture and use
US6375642B1 (en) * 2000-02-15 2002-04-23 Grieshaber & Co. Ag Schaffhausen Method of and device for improving a drainage of aqueous humor within the eye
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
EP1637126B1 (en) * 2000-07-05 2016-12-14 Allergan, Inc. Methods for treating inflammation of the eye
EP1339438B1 (en) 2000-11-29 2005-10-19 Allergan Inc. Preventing transplant rejection in the eye
US20040137059A1 (en) 2003-01-09 2004-07-15 Thierry Nivaggioli Biodegradable ocular implant
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
EP1711196A4 (en) 2003-12-05 2011-09-14 Bristol Myers Squibb Co INHIBITORS OF TYPE-2 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS
US8685435B2 (en) 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
US8802128B2 (en) 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8911496B2 (en) 2006-07-11 2014-12-16 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
MX2009000378A (es) 2006-07-11 2009-08-12 Refocus Group Inc Protesis escleral para tratar presbiopia y otros trastornos del ojo y dispositivos y metodos relacionados.
MX2009005466A (es) 2006-11-22 2009-08-17 Adnexus A Bristol Myers Sqibb Terapeuticos dirigidos a base de proteinas manipuladas para receptores de tirosina cinasas, incluyendo receptor de factor de crecimiento tipo insulina-i.
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US8231892B2 (en) 2007-05-24 2012-07-31 Allergan, Inc. Biodegradable drug delivery system
AU2009213141A1 (en) 2008-02-14 2009-08-20 Bristol-Myers Squibb Company Targeted therapeutics based on engineered proteins that bind EGFR
WO2009142773A2 (en) 2008-05-22 2009-11-26 Bristol-Myers Squibb Company Multivalent fibronectin based scaffold domain proteins
TWI496582B (zh) 2008-11-24 2015-08-21 必治妥美雅史谷比公司 雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子
JP6023703B2 (ja) 2010-05-26 2016-11-09 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 改善された安定性を有するフィブロネクチンをベースとする足場タンパク質
KR101750651B1 (ko) * 2016-01-28 2017-06-23 동국대학교 산학협력단 약물 잔류 방지능 및 재충전 기능을 갖는 안구 내 약물 주입 장치
CN106667656A (zh) * 2016-06-30 2017-05-17 广州聚明生物科技有限公司 生物可降解泪道栓及其制备方法和应用
US10512534B2 (en) * 2016-10-03 2019-12-24 California Institute Of Technology Radioluminescent phototherapy eye device
EP3746178B1 (en) 2018-01-31 2024-10-16 California Institute of Technology Controllable ocular phototherapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439198A (en) * 1981-07-09 1984-03-27 University Of Illinois Foundation Biodegradable ocular insert for controlled delivery of ophthalmic medication
US4634418A (en) * 1984-04-06 1987-01-06 Binder Perry S Hydrogel seton
US4863457A (en) * 1986-11-24 1989-09-05 Lee David A Drug delivery device
US5098443A (en) * 1989-03-23 1992-03-24 University Of Miami Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents
US5164188A (en) * 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
KR0185215B1 (ko) * 1990-11-30 1999-05-01 요시다 쇼오지 서방성 안구삽입용 약제
JPH04364857A (ja) * 1991-06-12 1992-12-17 Asahi Chem Ind Co Ltd 涙道せき止め用ロッド

Also Published As

Publication number Publication date
FI945014A7 (fi) 1994-10-25
NO303665B1 (no) 1998-08-17
FI945014L (fi) 1994-10-25
EP0654256A4 (en) 1995-01-04
WO1994018921A1 (en) 1994-09-01
KR950701209A (ko) 1995-03-23
NO944060D0 (no) 1994-10-25
FI945014A0 (fi) 1994-10-25
CA2118515A1 (en) 1994-02-23
EP0654256A1 (en) 1995-05-24
EP0654256B1 (en) 2000-08-02
PT654256E (pt) 2000-12-29
KR100313268B1 (ko) 2002-11-22
DE69425411D1 (de) 2000-09-07
GR3034526T3 (en) 2000-12-29
DK0654256T3 (da) 2000-12-18
DE69425411T2 (de) 2001-02-08
NO944060L (no) 1994-10-25
ATE195065T1 (de) 2000-08-15

Similar Documents

Publication Publication Date Title
ES2150487T3 (es) Tapon escleral biodegradable.
CO6450672A2 (es) Implantes lagrimales y métodos relacionados
AR039132A2 (es) Metodo para administrar un agente farmaceuticamente activo al ojo teniendo dicho ojo una esclerotica, una capsula de tenon y una macula
WO2005065079A3 (en) Medical implants and fibrosis-inducing agents
AR007356A1 (es) Protesis implantable
AR048645A1 (es) Tratamientos para el implante ocular de efecto terapeutico prolongado
MX9207402A (es) Dispositivo osmotico para surtir un agente benefico a la cavidad oral.
BR0010869A (pt) Método para administrar um corticosteróide a um segmento posterior de um olho e dispositivo de liberação sustentada implantável
AR036066A2 (es) Metodo para suministrar una droga a un ojo humano
DE60224817D1 (de) Stent-ablagevorrichtung mit embolieschutz
ES2194328T3 (es) Sistema de higiene femenina y kit que usa un dispositivo interlabial absorbente.
BR9508723A (pt) Implante método de implantação e dispositivo de aplicação
ATE369817T1 (de) Vorrichtung zur abgabe von therapeutischen wirkstoffen
AR029567A1 (es) Metodos para tratar estados del ojo mediados por inflamacion
SG170806A1 (en) Nasolacrimal drainage system implants for drug therapy
DE69941151D1 (de) Dreidimensionale prothesen mit hyaluronsäurederivaten
ATE343983T1 (de) Ophthalmologisches implantat
AR032151A1 (es) Uso de un farmaco anti-angiogenico en conjunto con un agente fotosensible para la preparacion de un medicamento para el tratamiento fotodinamico mejorado de la neovasculatura indeseada
AR032440A1 (es) Metodo para reducir o eliminar el tabaquismo
ES2234607T3 (es) Equipo concerniente al deposito de medicacion en la boca.
WO2020021137A1 (es) Aplicador de tampones
PE20000647A1 (es) Dispositivos para el manejo de excrementos humanos con medio flexible de fijacion a la piel
BR0215382A (pt) Método e implante intra-esclerótico para o tratamento de glaucoma e presbiopia
Chun et al. Salvage of ear replantation using the temporoparietal fascia flap
GT199800149A (es) Formulaciones parasiticidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 654256

Country of ref document: ES